Erythromycin and diffuse panbronchiolitis

Thorax

Volumn 52, Issue 10, 1997, Pages 915-918

  Koyama, Hiroshi ^a   Geddes, Duncan M ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; ERYTHROMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIBIOTIC THERAPY; BACTERICIDAL ACTIVITY; BRONCHIECTASIS; BRONCHIOLE; BRONCHIOLITIS; CHRONIC INFLAMMATION; CHRONIC SINUSITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; HAEMOPHILUS INFLUENZAE; JAPAN; LYMPHOCYTE FUNCTION; NEUTROPHILIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SEX DIFFERENCE; SPUTUM CULTURE; SURVIVAL RATE; THORAX RADIOGRAPHY;

EID: 0030869812     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.10.915     Document Type: Review

References (62)

1. Yamanaka A, Saeki S, Tamura S, Saito K. The problems of chronic obstructive pulmonary disease: especially concerning about diffuse panbronchiolitis (Japanese). Naika 1969;23:442-51.
2. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, Kira S, Izumi T. Diffuse panbronchiolitis - a disease of the transitional zone of the lung. Chest 1983; 83:63-9.
3. Iwata M, Colby TV, Kitaichi M. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum Pathol 1994;25:357-63.
4. Nishimura K, Kitaichi M, Izumi T, Itoh H. Diffuse panbronchiolitis: correlation of high resolution CT and pathologic findings. Radiology 1992;184:779-85.
5. Koyama H, Nishimura K, Mio T, Ikeda A, Sugiura N, Izumi T. Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis. Thorax 1994;49:540-4.
6. Izumi T. Diffuse panbronchiolitis (Japanese). Nihon Rinsha 1992;50(Suppl):386-94.
7. Tanimoto S, Homma H. Guideline for the diagnosis of panbronchiolitis: clinical diagnostic criteria. Annual report on the study of diffuse disseminated interstitial lung disease. Grant-in-Aid from the Ministry of Health and Welfare in Japan (Japanese), 1983: 49.
8. Hirata T, Nishikawa S, Izumi T. An immunological study on diffuse panbronchiolitis (English abstract). Nihon Kyobu Rinsho 1979;38:90 5.
9. Kusama S, Mochizuki I, Ozawa K, Izumi T, Homma H. Diffuse panbronchiolitis (Japanese). Nihon Rinsho 1983; 41(Suppl):393 400.
10. Izumi T. Diffuse panbronchiolitis. Chest 1991;100:596 7.
11. Kitaichi M. Diffuse panbronchiolitis current topics: pathology (Japanese). Medico 1990;21:9 11.
12. Randhawa P, Hoagland MH, Yousem SA. Diffuse panbronchiolitis in North America. Am J Surg Pathol 1991; 15:43-7.
13. Fitzgerald JE, King TE Jr, Lynch DA, Tuder RM. Schwarz MI. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med 1996;154:497 503.
14. Homer RJ, Khoo L, Walker Smith GJ. Diffuse panbronchiolitis in a Hispanic man with travel history to Japan. Chest 1995;107:11767 8.
15. Baz MA, Kussin PS, van Trigt P, Davis RD, Roggli VL, Tapson VF. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med 1995; 151:895-8.
16. Poletti V, Pateli M, Poletti G, Bertanti T, Spiga L. Diffuse panbronchiolitis observed in an Italian. Chest 1990;98: 515-6.
17. Tredaniel J, Zalcman G, Gerber F, D'Agay MF, Capron F, Frija J, et al. Diffuse panbronchiolitis: efficacy of low-dose erythromycin. Respir Med 1993;87:229 30.
18. Brugiere O, Milleron B, Antoine M, Carette M-F, Philippe C, Mayaud C. Diffuse panbronchiolitis in an Asian immigrant. Thorax 1996;51:1065 7.
19. Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1990;141:1459 62.
20. Danbara T, Matsuoka R, Nukiwa T, Natori H, Arai T, Kira S. Familial occurrence of diffuse panbronchiolitis accompanied with elevation of cold agglutinin titer in a father and his two daughters (English abstract). Jpn J Thorac Dis 1982;20:597 603.
21. Kudoh S, Uetake T, Hagiwara K, Hirayama M, Hus L-H, Kimura H, et al. Clinical effect of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis (English abstract). Jpn J Thorac Dis 1987;25:632 42.
22. Fujii T, Kadota J, Kawakami K, Iida K, Shirai R, Kaseda M, et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax 1995;50:1246 52.
23. Sawaki M, Mikami R, Mikasa K, Kunimatsu M, Ito S, Narita N. The long term chemotherapy with erythromycin in chronic lower respiratory tract infections - Second report: including cases with Pseudomonas infection (English abstract). J Jpn Assoc Infect Dis 1986;60:45 50.
24. Nagai H, Shishido H, Yoneda R, Yamaguchi F, Tamura A, Kurashima A. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991;58:145-9.
25. Ohno S, Sugiyama Y, Kitamura S. Clinical effects of lowdose and long-term erythromycin in diffuse panbronchiolitis with chronic respiratory failure (English abstract). Jpn J Thorac Dis 1993;31:1251-6.
26. Sawaki M, Mikami R, Mikasa K, Kunimatsu M, Ito S, Narita N. The long term chemotherapy with erythromycin in chronic lower respiratory tract infection First report: comparing with amoxicillin (English abstract). J Jpn Assoc Infect Dis 1986;60:37-44.
27. Yamamoto M. Therapeutic effect of erythromycin in patients with DPB - double blind trial (Japanese). Annual report on the study of diffuse disseminated interstitial lung disease. Grant-in-Aid from the Ministry of Health and Welfare in Japan. 1991: 18 20.
28. Takeda H, Miura H, Kawahira M, Kobayashi H. Long-term administration study on TE-031 (A-56268) in treatment of diffuse panbronchiolitis (English abstract). J Jpn Assoc Infect Dis 1989;63:71-8.
29. Ashitani J, Doutsu Y, Taniguchi H, Ii T, Matsukura S. A case of diffuse panbronchiolitis relieved rapidly by the treatment of roxithromycin (Japanese). J Jpn Assco Infect Dis 1992;66:657-8.
30. Kobayashi H, Takeda H, Sakayori S, Kawakami Y, Otsuka Y, Tamura M, et al. Study on azithromycin in treatment of diffuse panbronchiolitis (English abstract). J Jpn Assoc Infect Dis 1995;69:711-22.
31. Yamamoto M, Kondo A, Tamura M, Izumi T, Ina Y, Noda M. Long-term therapeutic effects of erythromycin and newquinolone antibacterial agents on diffuse panbronchiolitis (English abstract). Jpn J Thorac Dis 1990; 28:1305 13.
32. Ichikawa Y, Ninomiya H, Koga H, Tanaka M, Kinoshita M, Tokunaga N, et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992;146:196 203.
33. Oda H, Kadota J, Kohno S, Hara K. Erythromycin inhibits neutrophil chemotaxis in bronchoalveoli of diffuse panbronchiolitis. Cliest 1994;106:1110-23.
34. Nelson S, Summer WR, Terry PB, Warr GA, Jakab GJ. Erythromycin-indueed suppression of pulmonary antibacterial defences: a potential mechanism of superinfection in the lung. Am Rev Respir Dis 1987;136:1207 12.
35. Kadota J, Sakito O, Kohno S, Sawa H, Mukae H, Oda H, et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147:153 9.
36. Oishi K, Sonoda F, Kobayashi S, Iwagaki A, Nagatake T, Matsushima K, et al. Roie of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immnuol 1994;62:4145-52.
37. Iino Y, Toriyama M, Kudo K, Natori Y, Yuo A. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Owl Rhinol Laryngol 1992;101:16-20.
38. Akiyoshi H, Honda J, Nakahara S, Tokisawa S, Tokunaga N, Ichikawa Y, et al. Mechanism of efficacy of erythromycin on diffuse panbronchiolitis: effect of erythromycin on cytokine mRNA expression in human whole blood model (English abstract). J Jpn Assoc Infect Dis 1994;68:209 16.
39. Katahira J, Haruki K, Shibata Y, Kikuchi K, Hasegawa H, Totsuka K, et al. Stimulation of interleukin-1 and tumor necrosis factor production by oral erythromycin (English abstract). Chemotherapy (Japan) 1991;39:320 8.
40. Katahira J, Kikuchi K, Shibata Y, Hasegawa H, Totsuka K, Shimizu K. Kinetic studies on the effects of macrolides on cytokine production (English abstract), Chemotherapy (Japan) 1991;39:678 86.
41. Kadota J, Matsubara Y, Ishimatsu Y, Ashida M, Abe K, Shirai R, et al. Significance of IL-1ß and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol 1996;103:461 6.
42. Sakito O, Kadota J, Kohno S, Abe K, Shirai R, Hara K. Interleukin 1β, tumor necrosis factor alpha, and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy. Respiration 1996;63:42 8.
43. Oda H, Kadota J, Kohno S, Hara K. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Chest 1995;108:116 22.
44. Aoshiba K, Nagai A, Konno K. Erythromycin shortens neutrophil survival by accelerating apoptosis. Antimicrob Agents Chemother 1995;39:872 7.
45. Mukae H, Ashitani J, Nakazato M, Taniguchi H, Date Y, Ihi T, et al. A study of defensins in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis (English abstract). J Jpn Assoc Infect Dis 1995;69:975-81.
46. Kusano S, Mukae H, Morikawa T, Asai T, Sawa H, Morikawa N, et al. Effect of erythromycin on neutrophil adhesion molecules (English abstract). J Jpn Assoc Infect Dis 1993;67:7 11.
47. Radota J, Oda H, Sakito O, Sawa H, Morikawa N, Mukac H, et al. Effect of erythromycin on neutrophil function in chronic respiratory tract diseases with Pseudomonas infection (English abstract). J Jpn Assoc Infect Dis 1991; 65:277 85.
48. Yamasaki T. Adherence of Pseudomonas aeruginosa mouse tracheal epithelium: the effect of antimicrobial agents (English abstract). J Jpn Assoc Infect Dis 1990;64:575 83.
49. Masutani T, Sawaki M, Mikasa K, Konishi M, Yagyu Y, Narita N, et al. Inhibitory effect of erythromycin on elastase producing ability of Pseudomonas aeruginosa (Japanese). J Jpn Assoc Infect Dis 1989;63:1212 4.
50. Sakata K, Yajima H, Tanaka K, Sakamoto Y, Yamamoto K, Yoshida A, et al. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am Rev Respir Dis 1993;148:1061 5.
51. Takeda H, Oogaki N, Kikuchi N, Kobayashi H, Akashi T. A study to clarify the mechanism of the usefulness of the macrolides: the influence of clarithromycin to biofilm with P aeruginosa (English abstract). J Jpn Assoc Infect Dis 1992; 66:1454 61.
52. Yasuda H, Ajiki Y, Koga T, Kawada H, Yokota T. Interaction between biofilms formed by Pseudomanas aeruginosa and clarithromycin. Antimicrob Agents Chemother 1993;37: 1749 55.
53. Sato A, Chida K, Iwata M, Hayakawa H. Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolits. Am Rev Respir Dis 1992;146:473 8.
54. Sugiyama Y, Sugama Y, Takeuchi K, Kudoh S, Kitamura S. Analysis of peripheral lymphocyte subsets and changes due to erythromycin therapy in patients with diffuse panbronchiolitis (Japanese). Jpn J Thorac Dis 1990;28:1574 80.
55. Yanagihara K, Tomono K, Sawai T, Hirakata Y, Kadota J, Koga H, et al. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997;155:337 42.
56. Mukae H, Kadota J, Kohno S, Kusano S, Morikawa T, Matsukura S, et al. Increase in activated CD8+ cells in bronchoalveolar Iavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1995;152: 613-8.
57. Roche Y, Gougerot-Pocidalo M-A, Fay M, Forest N, Pocidalo J-J. Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation. J Antimicrob Chemother 1986;17:195 203.
58. Keicho N, Kudoh S, Yotsumoto H, Akagawa KS. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J Antibiot 1993;46:1406 13.
59. Mikasa K, Sawaki M, Konishi M, Egawa S, Yoneda T, Yagyu Y, et al. The effect of erythromycin treatment of natural killer cell activity in patients with chronic lower respiratory tract infection (English abstract). J Jpn Assoc Infect Dis 1989;63:811-5.
60. Goswami SK, Kivity S, Maron Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rec Respir Dis 1990;141:72-8.
61. Tamaoki J, Isonci K, Sakai N, Kanemura T, Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J 1992;5:234 8.
62. Tamaoki J, Nakata J, Takeda Y, Takemura H, Tagaya E, Konno K. Effect of macrolide antibiotics on airway goblet hypersecretion in guinea pigs (English abstract). J Jpn Assoc Infect Dis 1996;70:591 6.